Welcome to our dedicated page for Lionsgate studios SEC filings (Ticker: LION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lionsgate Studios Corp. (NYSE: LION) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a British Columbia–incorporated, NYSE‑listed studio business. These documents offer detailed insight into its motion picture and television production operations, capital structure and governance.
Annual reports (Form 10‑K) and quarterly reports (Form 10‑Q) present consolidated financial statements, segment information for the Motion Picture and Television Production businesses, management’s discussion and analysis, and discussions of liquidity, corporate debt and film‑related obligations. Investors can review how Lionsgate reports studio revenue, operating results, trailing 12‑month library revenue and backlog, as well as risk factors specific to its content and indebtedness profile.
Current reports on Form 8‑K include items such as earnings releases, credit facility amendments and shareholder meeting announcements. For example, Lionsgate has filed 8‑Ks describing quarterly results, amendments to the LG IP Credit Facility secured by intellectual property rights associated with library titles, and the timing and procedures for its initial annual general and special meeting of shareholders.
Registration statements, including the company’s amended Form S‑1, explain the separation of the studio business from the STARZ‑branded subscription platform, the listing of Lionsgate Studios Corp. shares on the NYSE under the symbol LION, and detailed information on capital stock, governance, executive and director compensation and risk factors.
Through Stock Titan, users can see new Lionsgate filings as they are made available via EDGAR and access AI‑generated summaries that highlight key points in lengthy documents. These summaries can help readers quickly understand complex sections on topics such as material indebtedness, film‑related obligations, shareholder rights and segment performance, while still allowing direct review of the full filings for deeper analysis.
Lionsgate Studios Corp. reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2026. Shareholder participation was high, with 90.92% of common shares entitled to vote represented in person or by proxy.
All nominated directors were elected to the Board, each receiving a strong majority of votes cast. Support ranged from 79.88% of shares voted for Michael T. Fries to 99.78% for Steven Mnuchin, indicating broad backing for the existing board slate.
Shareholders also approved the reappointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending March 31, 2026, with 99.63% of votes cast in favor. In addition, the advisory vote on executive compensation passed, receiving 80.19% of votes cast in support, signaling overall shareholder approval of the Company’s pay practices.
Lionsgate Studios Corp. registers 208,122 Common Shares under the 2025 Performance Incentive Plan to cover exercises of stock options and SARs held by former employees and their transferees. Proceeds from exercises will be used for general corporate purposes.
This Prospectus Supplement, dated March 18, 2026, supplements the Prospectus and attaches a Form 8-K filed on March 18, 2026 that reports final voting results from the Company’s Annual Meeting held March 17, 2026. The Common Shares trade on the NYSE under the symbol LION; the last reported sale price on March 17, 2026 was $9.68 per share.
Lionsgate Studios Corp. filed a prospectus supplement covering the exercise of stock options and stock appreciation rights to acquire up to 208,122 common shares held by certain former employees, with any cash proceeds to be used for general corporate purposes. The supplement also incorporates the company’s latest Quarterly Report and recent Current Reports.
For the quarter ended December 31, 2025, Lionsgate generated revenues of $724.3 million and operating income of $36.0 million, but reported a net loss attributable to shareholders of $46.2 million, or $0.16 per basic and diluted share. For the nine‑month period, revenue was $1.73 billion with a net loss of $268.5 million, or $0.95 per share, reflecting high interest expense, content amortization and restructuring costs.
At December 31, 2025, the company reported total assets of $5.24 billion, total liabilities of $6.38 billion and a shareholders’ equity deficit of $1.28 billion. Debt, excluding film‑related obligations, totaled $1.96 billion, alongside $2.06 billion of film‑related obligations, while cash and cash equivalents were $182.4 million and operating activities used $321.7 million of cash from continuing operations over nine months.
Lionsgate Studios Corp. reported higher quarterly revenue but continued losses as it operates as a standalone studio after the Starz separation. For the quarter ended December 31, 2025, revenue rose to $724.3 million from $628.2 million, reflecting stronger film and TV activity.
The company posted a net loss attributable to shareholders of $46.2 million, wider than the $21.9 million loss a year earlier, as interest expense and restructuring and other charges offset operating gains. For the first nine months, revenue was $1.73 billion with a net loss of $268.5 million.
Lionsgate is investing heavily in content, with investment in films and television programs increasing to $2.22 billion. It also carries substantial obligations, including $1.96 billion of corporate debt and $2.06 billion of film-related obligations. Shareholders’ equity remained in a deficit position of $1.28 billion, while cash and cash equivalents were $182.4 million.
Lionsgate Studios Corp. filed a current report stating that it issued a press release on February 5, 2026 announcing its results of operations for the third quarter ended December 31, 2025. The press release is furnished, not filed, as Exhibit 99.1 and incorporated by reference.
Lionsgate Studios Corp. calls an annual general and special meeting for March 17, 2026, asking shareholders to elect eleven directors, re-appoint Ernst & Young LLP as auditor, and approve executive compensation on an advisory basis. Holders of 290,187,242 common shares at 5:00 p.m. Eastern on February 2, 2026 may vote, with one vote per share.
The proxy describes Lionsgate’s separation from the former Lions Gate Entertainment into a focused studio company, now trading under ticker LION, and highlights a shift to a single-class, one‑share‑one‑vote structure. Governance changes include board refreshment and allowing a prior shareholder rights plan to expire.
Operationally, the company reports record fiscal 2025 studio revenue of $3.2 billion, a $1.1 billion fourth quarter, and record library revenue of $956 million, with a best‑ever $340 million library quarter. Motion Picture segment profit exceeded $300 million, STARZ (pre‑separation) generated over $200 million of segment profit with more than 70% digital revenue, and trailing 12‑month library revenue surpassed $1 billion. The board emphasizes franchise growth in film and television, strong renewal rates for scripted series, scaling of talent management operations, cost discipline, and early use of AI to boost productivity while protecting intellectual property.
Liberty 77 Capital L.P. and affiliated funds report a significant stake in Lionsgate Studios Corp. and enter into a governance agreement with board representation. The reporting group may be deemed to beneficially own up to 37,548,125 common shares, or 13.0% of Lionsgate Studios’ outstanding common shares, based on 289,729,314 shares outstanding as of November 3, 2025. Within this, Liberty 77 Fund L.P. holds 8,136,437 shares (2.8%) and Liberty 77 Fund International L.P. holds 29,411,688 shares (10.2%).
On January 26, 2026, Liberty 77 and its funds entered into a Governance, Standstill and Voting Agreement with Lionsgate Studios and MHR Fund Management. Under this agreement, Steven T. Mnuchin is appointed as a Liberty-designated director and added to the company’s director slate as long as the Liberty parties keep at least 5% ownership and he meets nomination requirements. Liberty 77 and MHR agree to vote their shares for each other’s board nominees and accept standstill restrictions, including limits on increasing ownership above 17.5% and on activist actions, for a period tied to the Liberty-designated director’s board service.
MHR Fund Management and affiliated funds filed Amendment No. 1 to their Schedule 13D on Lionsgate Studios Corp., updating their ownership and governance arrangements. The filing states that entities managed by MHR Fund Management may be deemed to beneficially own up to 37,920,093 common shares (about 13.1% of the 289,729,314 shares outstanding as of November 3, 2025), including restricted share units and shares held directly by Dr. Mark H. Rachesky.
The amendment describes a new Governance, Standstill and Voting Agreement with Liberty77 funds and Lionsgate, under which Steven T. Mnuchin is appointed to the board and will be nominated at future annual meetings while Liberty77 parties hold at least 5% of the common shares. MHR and the Liberty77 parties agree to vote their shares in favor of each other’s board nominees and accept standstill limits, including not raising ownership above 17.5%, along with transfer restrictions, derivative limits, and coordinated-action prohibitions. The agreement also grants pre-emptive, registration and “most favored nations” rights to MHR and Liberty77, subject to ownership thresholds.
Lionsgate Studios Corp. entered into a Governance, Standstill and Voting Agreement with Liberty 77 investment entities and MHR Fund Management. Under this agreement, Lionsgate appointed Steven T. Mnuchin as a Liberty-designated director on the Board, effective January 26, 2026, and will nominate him at upcoming annual shareholder meetings as long as the Liberty parties continue to own at least 5% of the company’s common shares and he meets governance requirements.
The Liberty and MHR parties agreed to vote their shares in favor of each other’s Board nominees and accepted restrictions on typical activist actions, including limits on increasing ownership above 17.5%, making unsolicited proposals, or launching proxy contests for a period tied to Mr. Mnuchin’s Board service. The agreement also includes transfer limits, derivative and hedging restrictions, pre-emptive and registration rights consistent with prior investor agreements, and certain most-favored-nations provisions that fall away once holdings drop below 20,000,000 common shares. The Board now has eleven directors and considers Mr. Mnuchin independent under NYSE rules.
Lionsgate Studios Corp. is scheduling its initial annual general and special meeting of shareholders for March 17, 2026 at its Canadian head office located at Dentons Canada LLP. This meeting will cover regular annual matters and any special items described in the upcoming proxy statement.
Shareholders who want their proposals included in the proxy statement under Rule 14a-8 must submit them by January 20, 2026. Shareholders wishing to nominate directors must meet the eligibility requirements in the Company’s articles and deliver notice to the secretary by February 13, 2026. Proposals and nomination notices may be sent to the Company’s secretary at the Vancouver registered office.